Myrtelle, Inc. is an innovative gene therapy company focused on transforming the treatment landscape for neurological diseases. With a patient-centered approach, Myrtelle harnesses cutting-edge biotechnology to develop advanced therapies aimed at improving the lives of individuals affected by these challenging conditions.
Gene therapy innovations, Cures for rare diseases, Transformative patient solutions, Root cause treatments, Biotechnology advancements
Uncork Capital
California, • United States
CRISPR Therapeutics
Massachusetts, • United States
Sarepta Therapeutics
Psychemedics Corporation
Massachusetts, • United States • Biotechnology
Hair drug testing technology, Patented drug extraction methods, Comprehensive substance detection, Court-validated test results, Expertise in toxicology and science
News & Media
Search Terms:
myrtelle
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Myrtelle belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Myrtelle?
Myrtelle specializes in Gene Therapy Innovations, Neurological Disease Treatments, Patient-Centered Care, Strategic Scientific Partnerships, Exclusive IP Collaborations.
What products and services is Myrtelle likely to offer?
Myrtelle offers Gene Therapies for Neurological Diseases, Innovative Biotechnological Solutions, Patient-Centered Treatment Services, Research and Development Collaborations, Manufacturing Partnerships.
Who are the competitors of Myrtelle?
Competitors of Myrtelle are Bluebird Bio, Sangamo Therapeutics, Rocket Pharmaceuticals, Uncork Capital, CRISPR Therapeutics, Sarepta Therapeutics, Psychemedics Corporation.
What does Myrtelle do?
Myrtelle, Inc. is an innovative gene therapy company focused on transforming the treatment landscape for neurological diseases. With a patient-centered approach, Myrtelle harnesses cutting-edge biotechnology to develop advanced therapies aimed at improving the lives of individuals affected by these challenging conditions.